News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
167,447 Results
Type
Article (6762)
Company Profile (79)
Press Release (160606)
Multimedia
Podcasts (7)
Webinars (1)
Section
Business (56682)
Career Advice (176)
Deals (11539)
Drug Delivery (10)
Drug Development (20529)
Employer Resources (24)
FDA (3602)
Job Trends (3565)
News (89775)
Policy (6785)
Tag
Academia (621)
Accelerated approval (3)
Adcomms (1)
Allergies (39)
Alliances (8079)
ALS (25)
Alzheimer's disease (359)
Antibody-drug conjugate (ADC) (60)
Approvals (3665)
Artificial intelligence (48)
Autoimmune disease (12)
Automation (4)
Bankruptcy (57)
Best Places to Work (3182)
Biosimilars (30)
Biotechnology (63)
Bladder cancer (47)
Brain cancer (11)
Breast cancer (153)
Cancer (1081)
Cardiovascular disease (74)
Career advice (155)
Career pathing (4)
CAR-T (57)
CDC (6)
Cell therapy (125)
Cervical cancer (12)
Clinical research (17694)
Collaboration (191)
Compensation (170)
Complete response letters (7)
COVID-19 (942)
CRISPR (12)
C-suite (56)
Cystic fibrosis (21)
Data (1332)
Depression (22)
Diabetes (119)
Diagnostics (1709)
Digital health (7)
Diversity, equity & inclusion (6)
Drug discovery (32)
Drug pricing (22)
Drug shortages (1)
Duchenne muscular dystrophy (32)
Earnings (40855)
Editorial (9)
Employer branding (4)
Employer resources (21)
Events (26478)
Executive appointments (89)
FDA (4298)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (206)
Gene editing (28)
Generative AI (3)
Gene therapy (90)
GLP-1 (256)
Government (1268)
Grass and pollen (3)
Guidances (281)
Healthcare (5390)
HIV (8)
Huntington's disease (8)
IgA nephropathy (11)
Immunology and inflammation (48)
Immuno-oncology (6)
Indications (13)
Infectious disease (988)
Inflammatory bowel disease (37)
Inflation Reduction Act (2)
Influenza (16)
Intellectual property (31)
Interviews (26)
IPO (7919)
IRA (5)
Job creations (535)
Job search strategy (136)
Kidney cancer (4)
Labor market (22)
Layoffs (127)
Leadership (4)
Legal (1072)
Liver cancer (17)
Lung cancer (187)
Lymphoma (99)
Machine learning (3)
Management (5)
Manufacturing (93)
MASH (40)
Medical device (3816)
Medtech (3822)
Mergers & acquisitions (3807)
Metabolic disorders (269)
Multiple sclerosis (41)
NASH (5)
Neurodegenerative disease (42)
Neuropsychiatric disorders (17)
Neuroscience (581)
NextGen: Class of 2025 (1303)
Non-profit (1066)
Now hiring (7)
Obesity (109)
Opinion (25)
Ovarian cancer (23)
Pain (20)
Pancreatic cancer (49)
Parkinson's disease (43)
Partnered (5)
Patents (56)
Patient recruitment (63)
Peanut (24)
People (8529)
Pharmaceutical (14)
Pharmacy benefit managers (3)
Phase I (4698)
Phase II (7607)
Phase III (6917)
Pipeline (1362)
Policy (25)
Postmarket research (608)
Preclinical (1662)
Press Release (12)
Prostate cancer (60)
Psychedelics (4)
Radiopharmaceuticals (125)
Rare diseases (125)
Real estate (866)
Recruiting (12)
Regulatory (5231)
Reports (17)
Research institute (469)
Resumes & cover letters (17)
Rett syndrome (7)
RNA editing (1)
RSV (20)
Schizophrenia (32)
Series A (25)
Series B (20)
Service/supplier (5)
Sickle cell disease (21)
Special edition (6)
Spinal muscular atrophy (49)
Sponsored (8)
Startups (543)
Stomach cancer (4)
Supply chain (10)
Tariffs (17)
The Weekly (6)
Vaccines (167)
Venture capital (10)
Weight loss (76)
Women's health (8)
Worklife (1)
Date
Today (39)
Last 7 days (188)
Last 30 days (615)
Last 365 days (8008)
2025 (6225)
2024 (9256)
2023 (10008)
2022 (11970)
2021 (31695)
2020 (19917)
2019 (10088)
2018 (7140)
2017 (6708)
2016 (5810)
2015 (7089)
2014 (4812)
2013 (3602)
2012 (3801)
2011 (4407)
2010 (4362)
Location
Africa (119)
Alabama (11)
Alaska (2)
Arizona (37)
Arkansas (3)
Asia (10041)
Australia (1181)
California (2094)
Canada (806)
China (202)
Colorado (114)
Connecticut (90)
Delaware (101)
Europe (24043)
Florida (290)
Georgia (93)
Idaho (13)
Illinois (219)
India (11)
Indiana (149)
Japan (94)
Kansas (21)
Kentucky (7)
Louisiana (6)
Maine (26)
Maryland (271)
Massachusetts (1589)
Michigan (78)
Minnesota (123)
Mississippi (1)
Missouri (15)
Montana (6)
Nebraska (1)
Nevada (21)
New Hampshire (18)
New Jersey (798)
New Mexico (2)
New York (583)
North Carolina (285)
Northern California (1042)
Ohio (57)
Oklahoma (1)
Oregon (12)
Pennsylvania (541)
Puerto Rico (2)
Rhode Island (4)
South America (203)
South Carolina (2)
Southern California (742)
Tennessee (44)
Texas (274)
United States (8081)
Utah (77)
Virginia (35)
Washington D.C. (11)
Washington State (195)
Wisconsin (18)
167,447 Results for "22".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MindMed Announces New Employee Inducement Grants - September 22, 2025
September 23, 2025
·
1 min read
Press Releases
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025
October 2, 2025
·
1 min read
Press Releases
Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds
September 18, 2025
·
5 min read
Press Releases
Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
September 19, 2025
·
5 min read
Press Releases
ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program
October 17, 2025
·
6 min read
Press Releases
IMFINZI® (durvalumab)-based regimen reduced the risk of death by 22% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial
October 20, 2025
·
19 min read
Vaccines
RFK Jr. Axes 22 mRNA Vaccine Projects Under BARDA
The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA vaccine development, a move that will affect several pharma companies, including Moderna, Pfizer, Sanofi and AstraZeneca.
August 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Digital Biomarkers Market Size Worth USD 31.82 Billion by 2034 Fueled by Rising Smartphone and Wearable Adoption at 22.71% CAGR
October 1, 2025
·
1 min read
Press Releases
RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures
October 7, 2025
·
3 min read
Press Releases
Omeros Corporation Announces Pricing of $22 Million Registered Direct Offering
July 28, 2025
·
4 min read
1 of 16,745
Next
